Matches in Wikidata for { <http://www.wikidata.org/entity/Q90881852> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q90881852 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90881852 description "scientific article published on 22 October 2019" @default.
- Q90881852 description "wetenschappelijk artikel" @default.
- Q90881852 description "наукова стаття, опублікована 22 жовтня 2019" @default.
- Q90881852 name "Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"" @default.
- Q90881852 name "Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"" @default.
- Q90881852 type Item @default.
- Q90881852 label "Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"" @default.
- Q90881852 label "Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"" @default.
- Q90881852 prefLabel "Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"" @default.
- Q90881852 prefLabel "Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"" @default.
- Q90881852 P1433 Q90881852-A891D4C0-F9D6-49C1-9C4F-9C48D32BD8E0 @default.
- Q90881852 P1476 Q90881852-78188861-FC21-4B53-9A5E-406B3C18A85A @default.
- Q90881852 P2093 Q90881852-1AB60173-9818-4B2D-926C-C7D97C16276F @default.
- Q90881852 P2093 Q90881852-52ACD841-25CD-4399-B8D3-89E2A08E9630 @default.
- Q90881852 P2093 Q90881852-92383E1A-979F-4432-95CD-2692B4E995C3 @default.
- Q90881852 P2093 Q90881852-A654A174-3178-45B3-A76B-4F31A6368ADE @default.
- Q90881852 P2093 Q90881852-EB02FB36-1302-41E6-9A98-FE9B27DEE472 @default.
- Q90881852 P31 Q90881852-C5AE0B9A-D3EB-4B66-A8C7-3E4DFD516F3B @default.
- Q90881852 P356 Q90881852-BCB43AB0-D876-4B61-97E0-5990065C5B34 @default.
- Q90881852 P433 Q90881852-75EA6085-A3E9-462E-9894-6BC268603E91 @default.
- Q90881852 P478 Q90881852-EE5730B0-3443-4D0D-847E-1312FE465323 @default.
- Q90881852 P50 Q90881852-04122E52-1EF6-4EEC-AB93-C38DEBDA2AA5 @default.
- Q90881852 P50 Q90881852-60CDB929-72C6-4878-BBBD-F7FA7DE69FD9 @default.
- Q90881852 P50 Q90881852-E042B0CE-9ECB-4CD4-9F1C-E09CFE502AD3 @default.
- Q90881852 P577 Q90881852-EDF2BE08-FCAB-4A90-BA1B-6F074E87B29A @default.
- Q90881852 P698 Q90881852-A53F4064-D2AC-4D0C-A632-493EC021D914 @default.
- Q90881852 P921 Q90881852-C3C5BCDA-9B3C-4C71-95D8-9640DD2071A5 @default.
- Q90881852 P932 Q90881852-C8E8B941-E848-4201-BA9E-099A03998358 @default.
- Q90881852 P356 AAC.01347-19 @default.
- Q90881852 P698 31640978 @default.
- Q90881852 P1433 Q578004 @default.
- Q90881852 P1476 "Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"" @default.
- Q90881852 P2093 "Fadi Haddad" @default.
- Q90881852 P2093 "Kerry LaPlante" @default.
- Q90881852 P2093 "Marcus Zervos" @default.
- Q90881852 P2093 "Matthew Geriak" @default.
- Q90881852 P2093 "Warren Rose" @default.
- Q90881852 P31 Q13442814 @default.
- Q90881852 P356 "10.1128/AAC.01347-19" @default.
- Q90881852 P433 "11" @default.
- Q90881852 P478 "63" @default.
- Q90881852 P50 Q106083571 @default.
- Q90881852 P50 Q117264083 @default.
- Q90881852 P50 Q7926191 @default.
- Q90881852 P577 "2019-10-22T00:00:00Z" @default.
- Q90881852 P698 "31640978" @default.
- Q90881852 P921 Q188121 @default.
- Q90881852 P932 "6811430" @default.